Efficacy of low-level laser therapy in the management of neck pain…

Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomized placebo or active-treatment controlled trials

Roberta T Chow 1, Mark I Johnson, Rodrigo A B Lopes-Martins, Jan M Bjordal


1 Nerve Research Foundation, Brain and Mind Research Institute, University of Sydney, Sydney, NSW, Australia. robertachow@iinet.net.au

PMID: 19913903
DOI: 10.1016/S0140-6736(09)61522-1


Background: Neck pain is a common and costly condition for which pharmacological management has limited evidence of efficacy and side-effects. Low-level laser therapy (LLLT) is a relatively uncommon, non-invasive treatment for neck pain, in which non-thermal laser irradiation is applied to sites of pain. We did a systematic review and meta-analysis of randomized controlled trials to assess the efficacy of LLLT in neck pain.

Methods: We searched computerized databases comparing the efficacy of LLLT using any wavelength with placebo or with active control in acute or chronic neck pain. The effect size for the primary outcome, pain intensity, was defined as a pooled estimate of mean difference in change in mm on a 100 mm visual analogue scale.

Findings: We identified 16 randomized controlled trials including a total of 820 patients. In acute neck pain, the results of the two trials showed a relative risk (RR) of 1.69 (95% CI 1.22-2.33) for pain improvement of LLLT versus placebo. Five trials of chronic neck pain reporting categorical data showed an RR for pain improvement of 4.05 (2.74-5.98) of LLLT. Patients in 11 trials reporting changes in visual analogue scale had pain intensity reduced by 19.86 mm (10.04-29.68). Seven trials provided follow-up data for 1-22 weeks after completion of treatment, with short-term pain relief persisting in the medium term with a reduction of 22.07 mm (17.42-26.72). Side-effects from LLLT were mild and not different from those of placebo.

Interpretation: We show that LLLT reduces pain immediately after treatment in acute neck pain and up to 22 weeks after completion of treatment in patients with chronic neck pain.

Funding: None.